These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32147502)

  • 41. Analysis of ageing-associated grey matter volume in patients with multiple sclerosis shows excess atrophy in subcortical regions.
    Bishop CA; Newbould RD; Lee JS; Honeyfield L; Quest R; Colasanti A; Ali R; Mattoscio M; Cortese A; Nicholas R; Matthews PM; Muraro PA; Waldman AD
    Neuroimage Clin; 2017; 13():9-15. PubMed ID: 27896065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subcortical Volumes as Early Predictors of Fatigue in Multiple Sclerosis.
    Fleischer V; Ciolac D; Gonzalez-Escamilla G; Grothe M; Strauss S; Molina Galindo LS; Radetz A; Salmen A; Lukas C; Klotz L; Meuth SG; Bayas A; Paul F; Hartung HP; Heesen C; Stangel M; Wildemann B; Then Bergh F; Tackenberg B; Kümpfel T; Zettl UK; Knop M; Tumani H; Wiendl H; Gold R; Bittner S; Zipp F; Groppa S; Muthuraman M;
    Ann Neurol; 2022 Feb; 91(2):192-202. PubMed ID: 34967456
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Sotirchos ES; Gonzalez-Caldito N; Dewey BE; Fitzgerald KC; Glaister J; Filippatou A; Ogbuokiri E; Feldman S; Kwakyi O; Risher H; Crainiceanu C; Pham DL; Van Zijl PC; Mowry EM; Reich DS; Prince JL; Calabresi PA; Saidha S
    Mult Scler; 2020 Mar; 26(3):312-321. PubMed ID: 30741108
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cortical and Subcortical Grey and White Matter Atrophy in Myotonic Dystrophies Type 1 and 2 Is Associated with Cognitive Impairment, Depression and Daytime Sleepiness.
    Schneider-Gold C; Bellenberg B; Prehn C; Krogias C; Schneider R; Klein J; Gold R; Lukas C
    PLoS One; 2015; 10(6):e0130352. PubMed ID: 26114298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of alexithymia in quality of life and health care use in asthma.
    Vazquez I; Sández E; González-Freire B; Romero-Frais E; Blanco-Aparicio M; Verea-Hernando H
    J Asthma; 2010 Sep; 47(7):797-804. PubMed ID: 20528585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Global and regional annual brain volume loss rates in physiological aging.
    Schippling S; Ostwaldt AC; Suppa P; Spies L; Manogaran P; Gocke C; Huppertz HJ; Opfer R
    J Neurol; 2017 Mar; 264(3):520-528. PubMed ID: 28054131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Grey Matter Atrophy in Multiple Sclerosis: Clinical Interpretation Depends on Choice of Analysis Method.
    Popescu V; Schoonheim MM; Versteeg A; Chaturvedi N; Jonker M; Xavier de Menezes R; Gallindo Garre F; Uitdehaag BM; Barkhof F; Vrenken H
    PLoS One; 2016; 11(1):e0143942. PubMed ID: 26745873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure of the alexithymic brain: A parametric coordinate-based meta-analysis.
    Xu P; Opmeer EM; van Tol MJ; Goerlich KS; Aleman A
    Neurosci Biobehav Rev; 2018 Apr; 87():50-55. PubMed ID: 29360475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasma levels of protein C pathway proteins and brain magnetic resonance imaging volumes in multiple sclerosis.
    Ziliotto N; Zivadinov R; Baroni M; Marchetti G; Jakimovski D; Bergsland N; Ramasamy DP; Weinstock-Guttman B; Straudi S; Manfredini F; Ramanathan M; Bernardi F
    Eur J Neurol; 2020 Feb; 27(2):235-243. PubMed ID: 31408242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microstructural white matter changes and their relation to neuropsychological deficits in patients with juvenile myoclonic epilepsy.
    Knake S; Roth C; Belke M; Sonntag J; Kniess T; Krach S; Jansen A; Sommer J; Paulus FM; Carl B; Rosenow F; Hermsen AM; Menzler K
    Epilepsy Behav; 2017 Nov; 76():56-62. PubMed ID: 28927715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alexithymia and reduced white matter integrity in schizophrenia: a diffusion tensor imaging study on impaired emotional self-awareness.
    Kubota M; Miyata J; Sasamoto A; Kawada R; Fujimoto S; Tanaka Y; Sawamoto N; Fukuyama H; Takahashi H; Murai T
    Schizophr Res; 2012 Nov; 141(2-3):137-43. PubMed ID: 22986045
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Affectivity and alexithymia: two dimensions explicative of the relationship between anxiety and depressive symptoms].
    Bonnet A; Bréjard V; Pasquier A; Pedinielli JL
    Encephale; 2012 Jun; 38(3):187-93. PubMed ID: 22726406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain correlates of alexithymia in eating disorders: A voxel-based morphometry study.
    D'Agata F; Caroppo P; Amianto F; Spalatro A; Caglio MM; Bergui M; Lavagnino L; Righi D; Abbate-Daga G; Pinessi L; Mortara P; Fassino S
    Psychiatry Clin Neurosci; 2015 Nov; 69(11):708-16. PubMed ID: 25967072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The left amygdala: A shared substrate of alexithymia and empathy.
    Goerlich-Dobre KS; Lamm C; Pripfl J; Habel U; Votinov M
    Neuroimage; 2015 Nov; 122():20-32. PubMed ID: 26275382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
    Zhang X; Zhang F; Huang D; Wu L; Ma L; Liu H; Zhao Y; Yu S; Shi J
    Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28035997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
    Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD
    Eur J Neurol; 2016 Apr; 23(4):817-22. PubMed ID: 26756564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deep gray matter atrophy in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Hyun JW; Park G; Kwak K; Jo HJ; Joung A; Kim JH; Lee SH; Kim S; Lee JM; Kim SH; Kim HJ
    Eur J Neurol; 2017 Feb; 24(2):437-445. PubMed ID: 28009104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M; Lotze M; Langner S; Dressel A
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.